Finance

Lists
002772:SHE
Tianshui Zhongxing Bio-technology Co Ltd
CNÂ¥11.57
+7.43%
(+0.80) 1D
Aug 18, 3:04:42 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002772...
Open
CNÂ¥10.81
High
CNÂ¥11.66
Low
CNÂ¥10.75
Mkt. cap
4.04B
Avg. vol.
13.98M
Volume
31.87M
Dividend
3.89%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 19, 2026
P/E ratio
9.74
52-wk high
CNÂ¥19.73
52-wk low
CNÂ¥7.80
EPS
CNÂ¥1.19
Shares outstanding
374.74M
No. of employees
9K
Open
CNÂ¥10.81
High
CNÂ¥11.66
Low
CNÂ¥10.75
Mkt. cap
4.04B
Avg. vol.
13.98M
Volume
31.87M
Dividend
3.89%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 19, 2026
P/E ratio
9.74
52-wk high
CNÂ¥19.73
52-wk low
CNÂ¥7.80
EPS
CNÂ¥1.19
Shares outstanding
374.74M
No. of employees
9K
About Tianshui Zhongxing Bio-technology Co Ltd
CEO-
Employees9.18K
FoundedNov 18, 2005
Headquarters-
SectorFood
Websitetszxjy.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
567.54M
622.98M
601.97M
483.38M
Cost of goods sold
371.41M
395.22M
365.10M
384.51M
Cost of revenue
371.41M
395.22M
365.10M
384.51M
Research and development expenses
4.67M
6.52M
2.59M
3.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
52.90M
84.05M
60.15M
66.15M
Operating expense
52.91M
109.07M
63.46M
57.81M
Total operating expenses
424.32M
504.28M
428.56M
442.31M
Operating income
143.22M
118.69M
173.41M
41.07M
Other non operating income
-9.91M
-8.09M
-3.31M
-23.10M
EBT including unusual items
135.71M
132.01M
163.34M
27.70M
EBT excluding unusual items
135.42M
108.65M
162.37M
25.71M
Income tax expense
-
1.21M
-
-
Effective tax rate
-
0.91%
-
-
Other operating expenses
-4.70M
17.66M
643.34K
-11.38M
Net income
135.33M
130.62M
162.70M
28.15M
Net profit margin
23.84%
20.97%
27.03%
5.82%
Earnings per share
-
-
-
-
Interest and investment income
7.38M
7.90M
6.88M
14.61M
Interest expense
-14.07M
-15.75M
-14.61M
-6.88M
Net interest expenses
-6.69M
-7.85M
-7.74M
7.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
214.81M
196.62M
251.34M
105.78M
Gain or loss from assets sale
-4.38M
6.54M
-
6.00M
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps